Evidence map›Paper›PMID 36419842›Full record

ArticleDisease markers2022

Fahimeh Mirzaei Gheinari, Fatemeh Sakhaee, Melika Gholami, Fattah Sotoodehnejadnematalahi, Mohammad Saber Zamani, Iraj Ahmadi, Enayat Anvari, Abolfazl Fateh

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Disease markers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Fahimeh Mirzaei GheinariDepartment of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Fatemeh SakhaeeDepartment of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Melika GholamiDepartment of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Fattah SotoodehnejadnematalahiDepartment of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Mohammad Saber ZamaniImmunoregulation Research Center, Shahed University, Tehran, Iran.
Iraj AhmadiDepartment of Physiology, School of Medicine, Ilam University of Medical Science, Ilam, Iran.
Enayat AnvariDepartment of Physiology, School of Medicine, Ilam University of Medical Science, Ilam, Iran.
Abolfazl FatehDepartment of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0000-0002-2043-8523
Pasteur Institute of Iran · IRIlam University · IRIslamic Azad University, Science and Research Branch · IRShahed University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies have discovered a relationship between specific blood types, genetic variations of the

Indexed as

ABO Blood-Group SystemCOVID-19GenotypeHumansIranPolymorphism, GeneticABO Blood-Group System

Identifiers

PMID36419842
PMCPMC9678483
OpenAlexW4308985902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.